New drug SSS67: first human tests begin in healthy volunteers
NCT ID NCT07487545
First seen Apr 05, 2026 · Last updated May 12, 2026 · Updated 4 times
Summary
This early-stage study tests a single dose of an experimental drug, SSS67, in 52 healthy adults to see if it is safe and how the body processes it. Participants receive either the drug or a placebo by IV, and researchers monitor for side effects, drug levels, and immune responses. No treatment benefit is expected; the goal is to gather safety data for future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Novatrials
Charlestown, New South Wales, 2290, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.